Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Dominant mutations in superoxide dismutase cause amyotrophic lateral sclerosis (ALS), a progressive paralytic disease characterized by loss of motor neurons. With the use of mice carrying a deletable mutant gene, expression within motor neurons was shown to be a primary determinant of disease onset and of an early phase of disease progression. Diminishing the mutant levels in microglia had little effect on the early disease phase but sharply slowed later disease progression. Onset and progression thus represent distinct disease phases defined by mutant action within different cell types to generate non–cell-autonomous killing of motor neurons; these findings validate therapies, including cell replacement, targeted to the non-neuronal cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“accumulation of mutant SOD1 in microglia may further amplify their proinflammatory and neurotoxic activity (149, 150).”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [150]
Citations
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Generalized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 4,859
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
Srinivas, S., Watanabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M., & Costantini, F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-4 · Cited by 3,121
Microglia as a source and target of cytokines
Hanisch, U. (2002) · Glia · doi:10.1002/glia.10161 · Cited by 1,645
Wong, P. C., Pardo, C. A., Borchelt, D. R., Lee, M. K., Copeland, N. G., Jenkins, N. A., Sisodia, S. S., Cleveland, D. W., & Price, D. L. (1995) · Neuron · doi:10.1016/0896-6273(95)90259-7 · Cited by 1,445
Self-citationBruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., Sisodia, S. S., Rothstein, J. D., Borchelt, D. R., Price, D. L., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80272-x · Cited by 1,341
Self-citationUNRAVELING THE MECHANISMS INVOLVED IN MOTOR NEURON DEGENERATION IN ALS
Bruijn, L. I., Miller, T. M., & Cleveland, D. W. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144244 · Cited by 1,185
Self-citationWild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice
Clement, A. M., Nguyen, M. D., Roberts, E. A., Garcia, M. L., Boillée, S., Rule, M., McMahon, A. P., Doucette, W., Siwek, D., Ferrante, R. J., et al. (2003) · Science · doi:10.1126/science.1086071 · Cited by 1,100
Self-citation
Research works printed but not linked: 2
- T. Kawamata, H. Akiyama, T. Yamada, P. L. McGeer, Am. J. Pathol.140, 691 (1992).
- A. Mazzone, G. Ricevuti, Haematologica80, 161 (1995).
Cited by
Items 901–1,000 of 1,001
Neurodegenerative disease-specific induced pluripotent stem cell research
Inoue, H. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.04.022 · Cited by 36
Lee, J., Kawaguchi, Y., Li, M., Kapur, M., Choi, S. J., Kim, H.-J., Park, S.-Y., Zhu, H., & Yao, T. (2015) · Neurodegenerative Diseases · doi:10.1159/000437208 · Cited by 31
CSF profiles of angiogenic and inflammatory factors depend on the respiratory status of ALS patients
Moreau, C., Gosset, P., Danel-Brunaud, V., Lassalle, P., Degonne, B., Destée, A., Defebvre, L., & Devos, D. (2009) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802651725 · Cited by 31
Status of ALS treatment, insights into therapeutic challenges and dilemmas
Khamaysa, M., & Pradat, P.-F. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12101601 · Cited by 28
Ghadge, G. D., Kay, B. K., Drigotas, C., & Roos, R. P. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.08.021 · Cited by 28
Ovsepian, S. V., O’Leary, V. B., & Martínez, S. (2023) · Brain Structure and Function · doi:10.1007/s00429-023-02728-6 · Cited by 34
Microglia in ALS: Insights into Mechanisms and Therapeutic Potential
Bond, S., Saxena, S., & Sierra-Delgado, J. A. (2025) · Cells · doi:10.3390/cells14060421 · Cited by 35
Links between Electrophysiological and Molecular Pathology of Amyotrophic Lateral Sclerosis
Quinlan, K. A. (2011) · Integrative and Comparative Biology · doi:10.1093/icb/icr116 · Cited by 32
The Importance of Non-neuronal Cell Types in hiPSC-Based Disease Modeling and Drug Screening
Gonzalez, D. M., Gregory, J. K., & Brennand, K. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00117 · Cited by 28
A small-molecule inhibitor of SOD1-Derlin-1 interaction ameliorates pathology in an ALS mouse model
Tsuburaya, N., Homma, K., Higuchi, T., Balia, A. G., Yamakoshi, H., Shibata, N., Nakamura, S., Nakagawa, H., Ikeda, S., Umezawa, N., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05127-2 · Cited by 30
Ca2+-activated K+ channels modulate microglia affecting motor neuron survival in hSOD1G93A mice
Cocozza, G., Castro, M. A. D., Carbonari, L., Grimaldi, A., Antonangeli, F., Garofalo, S., Porzia, A., Madonna, M., Mainiero, F., Santoni, A., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.07.002 · Cited by 30
Translatomic analysis of regenerating and degenerating spinal motor neurons in injury and ALS
Shadrach, J. L., Stansberry, W. M., Milen, A. M., Ives, R. E., Fogarty, E. A., Antonellis, A., & Pierchala, B. A. (2021) · iScience · doi:10.1016/j.isci.2021.102700 · Cited by 28
Carata, E., Muci, M., Giulio, S. D., Mariano, S., & Panzarini, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411251 · Cited by 35
Microglial crosstalk with astrocytes and immune cells in amyotrophic lateral sclerosis
Calafatti, M., Cocozza, G., Limatola, C., & Garofalo, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1223096 · Cited by 34
Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants
Marchi, F. D., Tondo, G., Corrado, L., Menegon, F., Aprile, D., Anselmi, M., D’Alfonso, S., Comi, C., & Mazzini, L. (2023) · Genes · doi:10.3390/genes14081658 · Cited by 34
Younger, D. S., & Brown, R. H. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98817-9.00031-4 · Cited by 40
Novel Molecular Biomarkers at the Blood-Brain Barrier in ALS
Bataveljic, D., Milosevic, M., Radenovic, L., & Andjus, P. (2014) · BioMed Research International · doi:10.1155/2014/907545 · Cited by 28
Sargsyan, S. A., Blackburn, D. J., Barber, S. C., Großkreutz, J., Vos, K. J. D., Monk, P. N., & Shaw, P. J. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-91 · Cited by 35
The in vivo contribution of motor neuron TrkB receptors to mutant SOD1 motor neuron disease
Zhai, J., Zhou, W., Li, J., Hayworth, C. R., Zhang, L., Misawa, H., Klein, R., Scherer, S. S., Balice‐Gordon, R. J., & Kalb, R. G. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr335 · Cited by 29
Dobrowolny, G., Bernardini, C., Martini, M., Baranzini, M., Barba, M., & Musarò, A. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00463 · Cited by 29
Lessons Learned about Neurodegeneration from Microglia and Monocyte Depletion Studies
Lund, H., Pieber, M., & Harris, R. A. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00234 · Cited by 28
The Microglial Response to Neurodegenerative Disease
Song, W. M., & Colonna, M. (2018) · Advances in immunology · doi:10.1016/bs.ai.2018.04.002 · Cited by 30
RNA quality control and protein aggregates in amyotrophic lateral sclerosis: A review
Verma, A. K., & Tandan, R. (2012) · Muscle & Nerve · doi:10.1002/mus.23673 · Cited by 28
Cellular transplants in amyotrophic lateral sclerosis patients: an observational study
Gámez, J., Carmona, F., Raguer, N., Ferrer, J., Martín-Henao, G. A., Martí, S., Badia, M., Gratacos, M., Rodríguez, E., Seoane, J. L., et al. (2010) · Cytotherapy · doi:10.3109/14653241003774037 · Cited by 27
Binukumar, B. K., Skuntz, S., Prochazkova, M., Kesavapany, S., Amin, N. D., Shukla, V., Grant, P. G., Kulkarni, A. B., & Pant, H. C. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz118 · Cited by 29
Bonifacino, T., Rebosio, C., Provenzano, F., Torazza, C., Balbi, M., Milanese, M., Raiteri, L., Usai, C., Fedele, E., & Bonanno, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184552 · Cited by 27
Yang, Y., Zheng, Y.-H., Zhang, C., Liang, W., Wang, S., Wang, X., Wang, Y., Wang, T., Jiang, H., & Feng, H. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104648 · Cited by 27
Prionoids in amyotrophic lateral sclerosis
Gosset, P., Camu, W., Raoul, C., & Mezghrani, A. (2022) · Brain Communications · doi:10.1093/braincomms/fcac145 · Cited by 38
Hernández, S., Casanovas, A., Piedrafita, L., Tarabal, O., & Esquerda, J. E. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181cd3e33 · Cited by 29
Harandi, V. M., Lindquist, S., Kolan, S. S., Brännström, T., & Liu, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109833 · Cited by 28
Marco, G. D., Lomartire, A., Calvo, A., Risso, A., Luca, E. D., Mostert, M., Mandrioli, J., Caponnetto, C., Borghero, G., Manera, U., et al. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12328 · Cited by 31
Vilmont, V., Cadot, B., Vezin, E., Grand, F. L., & Gomes, E. R. (2016) · Scientific Reports · doi:10.1038/srep27804 · Cited by 27
Neuroinflammation and Neurodegeneration
Morales, I., Farias, G. A., Cortés, N., & Maccioni, R. B. (2016) · InTech eBooks · doi:10.5772/64545 · Cited by 41
Chemistry and Chemical Equilibrium Dynamics of BMAA and Its Carbamate Adducts
Diaz-Parga, P., Goto, J. J., & Krishnan, V. V. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9801-2 · Cited by 30
Landoni, L. M., Myles, J. R., Wells, T. L., Mayer, W. P., & Akay, T. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.111914 · Cited by 30
Bedlack, R., Traynor, B. J., & Cudkowicz, M. (2007) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.12.2.229 · Cited by 29
David, G., Nguyen, K. T. V., & Barrett, E. F. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.12.021 · Cited by 30
Modulators of microglia: a patent review
Papa, S., Caron, I., Rossi, F., & Veglianese, P. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2016.1135901 · Cited by 29
Solomonov, Y., Hadad, N., & Lévy, R. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0602-y · Cited by 30
Hochu-Ekki-To Improves Motor Function in an Amyotrophic Lateral Sclerosis Animal Model
Cai, M., & Yang, E. J. (2019) · Nutrients · doi:10.3390/nu11112644 · Cited by 29
Nataf, S., Guillen, M., & Pays, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02704 · Cited by 27
Studying ALS: Current Approaches, Effect on Potential Treatment Strategy
Ustyantseva, E., Medvedev, S. P., & Zakian, S. M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-41283-8_11 · Cited by 28
Salvany, S., Casanovas, A., Piedrafita, L., Gras, S., Calderó, J., & Esquerda, J. E. (2022) · Brain Pathology · doi:10.1111/bpa.13078 · Cited by 28
Parkhouse, W. S., Cunningham, L., McFee, I. J. L., Miller, J. M., Whitney, D. C., Pelech, S., & Krieger, C. (2008) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960701725646 · Cited by 29
Bonini, M. G., Gabel, S. A., Ranguelova, K., Stadler, K., DeRose, E. F., London, R. E., & Mason, R. P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m804644200 · Cited by 26
Transcriptome Profiling Following Neuronal and Glial Expression of ALS-Linked SOD1 inDrosophila
Kumimoto, E. L., Fore, T. R., & Zhang, B. (2013) · G3 Genes Genomes Genetics · doi:10.1534/g3.113.005850 · Cited by 30
Let’s make microglia great again in neurodegenerative disorders
Guillot‐Sestier, M., & Town, T. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1792-x · Cited by 31
Inflammation, immunity, and amyotrophic lateral sclerosis: II. immune‐modulating therapies
Wosiski‐Kuhn, M., Lyon, M. S., Caress, J. B., & Milligan, C. (2018) · Muscle & Nerve · doi:10.1002/mus.26288 · Cited by 30
Wu, R. J., Wang, H., Xia, X., Zhou, H., Liu, C., Castro, M. G., & Xu, Z. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2618 · Cited by 26
Bigini, P., Repici, M., Cantarella, G., Fumagalli, E. R., Barbera, S., Cagnotto, A., Luigi, A. D., Tonelli, R., Bernardini, R., Borsello, T., et al. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.11.005 · Cited by 26
Neuronal–glial communication perturbations in murine SOD1G93A spinal cord
MacLean, M., López‐Díez, R., Vásquez, C., Gugger, P. F., & Schmidt, A. M. (2022) · Communications Biology · doi:10.1038/s42003-022-03128-y · Cited by 26
Amyotrophic Lateral Sclerosis — Are Microglia Killing Motor Neurons?
Borchelt, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmcibr064358 · Cited by 25
PTEN regulates AMPA receptor-mediated cell viability in iPS-derived motor neurons
Yang, D., Wang, X.-L., Ismail, A., Ashman, C. J., Valori, C. F., Wang, G., Gao, S., Higginbottom, A., Ince, P. G., Azzouz, M., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.55 · Cited by 27
Qiu, L., Rivera‐Pérez, J. A., & Xu, Z. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018778 · Cited by 24
Gubert, F., Decotelli, A. B., Bonacossa-Pereira, I., Figueiredo, F. R., Zaverucha-do-Valle, C., Tovar-Moll, F. F., Hoffmann, L., Ürményi, T. P., Santiago, M. F., & Méndez‐Otero, R. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0293-4 · Cited by 25
Yin, X. L., Wang, S., Qi, Y., Wang, X., Jiang, H., Wang, T., Yang, Y., Wang, Y., Zhang, C., & Feng, H. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.05.004 · Cited by 25
Could sirtuin activities modify ALS onset and progression?
Tang, B. L. (2017) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0452-2 · Cited by 24
Tamai, S.-I., Imaizumi, K., Kurabayashi, N., Nguyen, M. D., Abe, T., Inoue, M., Fukada, Y., & Sanada, K. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.524389 · Cited by 22
Ferraiuolo, L., & Maragakis, N. J. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135911 · Cited by 30
Evolving Models and Tools for Microglial Studies in the Central Nervous System
Zhang, Y., & Cui, D. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00706-8 · Cited by 25
Glial Metabolic Reprogramming in Amyotrophic Lateral Sclerosis
Cassina, P., Miquel, E., Palma, L. M., & Cassina, A. (2021) · NeuroImmunoModulation · doi:10.1159/000516926 · Cited by 26
Microglia in motor neuron disease: Signaling evidence from last 10 years
Wang, M., Lu, K., Wang, Y., Yang, B., Zhang, C., Lu, Y., & Kang, L. (2022) · Developmental Neurobiology · doi:10.1002/dneu.22905 · Cited by 26
Expression of ALS-PFN1 impairs vesicular degradation in iPSC-derived microglia
Funes, S., Jung, J., Gadd, D. H., Mosqueda, M., Zhong, J., Shankaracharya, Unger, M., Stallworth, K. M., Cameron, D., Rotunno, M. S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46695-w · Cited by 30
Brain–body mechanisms contribute to sexual dimorphism in amyotrophic lateral sclerosis
Jacob, S. M., Lee, S., Kim, S. H., Sharkey, K. A., Pfeffer, G., & Nguyen, M. D. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00991-7 · Cited by 27
Evangelidou, M., Καραμίτα, Μ., Vamvakas, S. M., Szymkowski, D. E., & Probert, L. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1300633 · Cited by 27
Advances in Cellular Models to Explore the Pathophysiology of Amyotrophic Lateral Sclerosis
Veyrat‐Durebex, C., Corcia, P., Dangoumau, A., Laumonnier, F., Piver, É., Gordon, P. H., Andres, C. R., Vourc’h, P., & Blasco, H. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8573-9 · Cited by 31
Wang, Y., Liu, L., Ma, L., Huang, X., Lou, X., Wang, Y., Nan-zhou, W., Liu, T., & Guo, X. (2014) · Academic Radiology · doi:10.1016/j.acra.2014.01.014 · Cited by 24
Infection of the Central Nervous System, Sepsis and Amyotrophic Lateral Sclerosis
Fang, F., Chen, H., Wirdefeldt, K., Ronnevi, L., Al‐Chalabi, A., Peters, T. L., Kamel, F., & Ye, W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029749 · Cited by 25
Roles of glial cells in neuroinflammation and neurodegeneration
Takeuchi, H. (2013) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12059 · Cited by 30
Adeno Associated Viral Vector Delivered RNAi for Gene Therapy of SOD1 Amyotrophic Lateral Sclerosis
Stoica, L., & Sena‐Esteves, M. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00056 · Cited by 27
Tokuda, E., Anzai, I., Nomura, T., Toichi, K., Watanabe, M., Ohara, S., Watanabe, S., Yamanaka, K., Morisaki, Y., Misawa, H., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0145-9 · Cited by 24
Self-citationEl‐Kadi, A. M., Bros‐Facer, V., Deng, W., Philpott, A., Stoddart, E., Banks, G. T., Jackson, G. S., Fisher, E., Duchen, M. R., Greensmith, L., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.129320 · Cited by 27
Microglia in amyotrophic lateral sclerosis.
Dewil, M., Bosch, L. V. D., & Robberecht, W. (2007) · PubMed · Cited by 28
Polymenidou, M., & Cleveland, D. W. (2008) · Nature · doi:10.1038/454284a · Cited by 24
Self-citationReduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosis
Rué, L., Oeckl, P., Timmers, M., Lenaerts, A., van der Vos, J., Smolders, S., Poppe, L., de Boer, A., Bosch, L. V. D., Damme, P. V., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0759-6 · Cited by 27
Neel, D. V., Basu, H., Gunner, G., & Chiu, I. M. (2022) · Immunological Reviews · doi:10.1111/imr.13083 · Cited by 22
Gerber, Y. N., Sabourin, J.-C., Hugnot, J., & Perrin, F. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045503 · Cited by 29
Assessing the role of immuno-proteasomes in a mouse model of familial ALS
Puttaparthi, K., Kaer, L. V., & Elliott, J. L. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.03.024 · Cited by 23
The Spatiotemporal Pattern of Degeneration in the Cerebellum of the Wobbler Mouse
Saberi, D., Ott, B., Dahlke, C., Matschke, V., Schmitt‐John, T., & Theiß, C. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw005 · Cited by 23
Lei, H., Dirren, E., Poitry‐Yamate, C., Schneider, B. L., Gruetter, R., & Aebischer, P. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18756499 · Cited by 24
Gene therapy breakthroughs in ALS: a beacon of hope for 20% of ALS patients
Xie, Q., Li, K., Chen, Y., Li, Y., Jiang, W., Cao, W., Yu, H., Fan, D., & Deng, B. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00477-6 · Cited by 27
From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis
Alrafiah, A. (2018) · In Vivo · doi:10.21873/invivo.11339 · Cited by 30
Nakamura, Y., Kimura, S., Takada, N., Takemura, M., Iwamoto, M., Hisaoka‐Nakashima, K., Nakata, Y., & Morioka, N. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104751 · Cited by 21
Marton, S., Miquel, E., Acosta-Rodríguez, J., Fontenla, S., Libisch, G., & Cassina, P. (2023) · ASN NEURO · doi:10.1177/17590914231197527 · Cited by 27
Zaccai, S., Nemirovsky, A., Lerner, L., Alfahel, L., Eremenko, E., Israelson, A., & Monsonego, A. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-023-03007-1 · Cited by 25
A Review of Biomarkers of Amyotrophic Lateral Sclerosis: A Pathophysiologic Approach
Alshehri, R. S., Abuzinadah, A. R., Alrawaili, M. S., Alotaibi, M. K., Alsufyani, H. A., Alshanketi, R. M., & Alshareef, A. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010900 · Cited by 26
Lovett, M., Coates, J. R., Shu, Y., Oglesbee, M., Fenner, W. R., & Moore, S. A. (2014) · The Veterinary Journal · doi:10.1016/j.tvjl.2014.03.003 · Cited by 23
D-amino acids in normal ageing and pathogenesis of neurodegenerative diseases
Chervyakov, A. V., Gulyaeva, N. V., & Zakharova, M. N. (2011) · Neurochemical Journal · doi:10.1134/s1819712411020036 · Cited by 28
Utilizing past and present mouse systems to engineer more relevant pancreatic cancer models
DeCant, B. T., Principe, D. R., Guerra, C. E., di Magliano, M. P., & Grippo, P. J. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00464 · Cited by 24
Recent Advances and the Future of Stem Cell Therapies in Amyotrophic Lateral Sclerosis
Goutman, S. A., Chen, K. S., & Feldman, E. L. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0339-9 · Cited by 25
Qi, Y., Yin, X. L., Wang, S., Jiang, H., Wang, X., Ren, M., Su, X.-P., Shi, L., & Feng, H. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00204 · Cited by 24
Prado, L. D. G. R., Rocha, N. P., de Souza, L. C., Bicalho, I. C. S., Gómez, R. S., Vidigal-Lopes, M., Braz, N. F. T., Vieira, É. L. M., & Teixeira, A. L. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.08.033 · Cited by 26
Bonifacino, T., Provenzano, F., Gallia, E., Ravera, S., Torazza, C., Bossi, S., Ferrando, S., Puliti, A., Bosch, L. V. D., Bonanno, G., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.05.007 · Cited by 23
Dong, J., Liu, X., Wang, Y. Y., Cai, H., & Le, W. (2020) · Glia · doi:10.1002/glia.23826 · Cited by 24
Seo, J., Choi, J., Leem, Y., & Han, P. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.4.341 · Cited by 23
Ramírez-Jarquín, U. N., Rojas, F., van Zundert, B., & Tapia, R. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25827 · Cited by 25
Park, K. H. J., & Vincent, I. J. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.04.001 · Cited by 24
Liebl, M. P., Windschmitt, J., Besemer, A. S., Schäfer, A.-K., Reber, H., Behl, C., & Clement, A. M. (2015) · Scientific Reports · doi:10.1038/srep08585 · Cited by 25
Hartung, V., Prell, T., Christian Gaser, B., Turner, M. R., Tietz, F., Ilse, B., Bokemeyer, M., Witte, O. W., & Großkreutz, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104894 · Cited by 21
Tejwani, L., Jung, Y., Kokubu, H., Sowmithra, S., Ni, L., Lee, C., Sanders, B., Lee, P. J., Xiang, Y., Luttik, K., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci138207 · Cited by 17
“In addition to increasing overall survival, disease onset, which was defined as the first time point in which weight gain was no longer observed (35, 36), was delayed in male mice with a 50% genetic reduction of Nlk (Supplemental Figure 7C).”
Background
Metadata
- Authors
- Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W.
- Affiliations
- Ludwig Institute for Cancer Research and Departments of Medicine and Neuroscience, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.
- University of California San Diego (US)
- ORCID
- Venue
- Science
- Published
- 2006-06-02
- Volume
- 312
- Issue
- 5778
- Pages
- 1389-1392
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2033158384
- Cited by
- 1,623
- References
- 28
- Citations by year
- 2026: 42 · 2025: 40 · 2024: 52 · 2023: 59 · 2022: 69 · 2021: 60 · 2020: 95 · 2019: 82 · 2018: 74 · 2017: 84 · 2016: 82 · 2015: 81 · 2014: 109 · 2013: 107 · 2012: 115
- FWCI
- 66.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS 27036, R37NS027036)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- amyotrophic lateral sclerosis, motor neurons, microglia, disease onset, disease progression, cell replacement therapy, mouse model
- MeSH terms
- Superoxide Dismutase-1, Amyotrophic Lateral Sclerosis, Animals, Female, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Motor Neurons, Mutation, Superoxide Dismutase, Microglia, Disease Progression, Integrases, CD11b Antigen, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.